Furan fatty acids – Beneficial or harmful to health?

Long Xu, Andrew J. Sinclair, Muniba Faiza, Daoming Li, Xianlin Han, Huiyong Yin, Yonghua Wang

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

Furan fatty acids are found in plants, algae, and fish, and reported to have some positive health benefits, including anti-oxidant and anti-inflammatory activities, and inhibition of non-enzymatic lipid peroxidation. A major metabolite of furan fatty acids, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF), has been reported to be increased in patients who progress from prediabetes to type 2 diabetes, although CMPF is not necessarily associated with impaired glucose metabolism. Other studies report that CMPF levels are lower in subjects with diabetes than control subjects. Plasma CMPF levels increase in subjects who consume fish or fish oil, and in patients with renal failure. It is not known where furan fatty acids are converted to CMPF and it is speculated that this might be a result of microbiome activity. The plasma levels reported for CMPF in healthy, diabetic and patients with renal disease vary by factors of more than 100-fold within each of these three groups, so measurement error appears to be limiting the ability to interpret studies. This review explores these controversies and raises questions about whether CMPF is a marker for healthy diets or indeed associated with diabetes and renal health. The review concludes that, on balance, furan fatty acids are beneficial for health.

Original languageEnglish (US)
Pages (from-to)119-137
Number of pages19
JournalProgress in Lipid Research
Volume68
DOIs
StatePublished - Oct 1 2017

Fingerprint

Fatty Acids
Health
Acids
Medical problems
Fish
Fishes
Kidney
Plasmas
Prediabetic State
Aptitude
Fish Oils
Microbiota
Insurance Benefits
Algae
Nutrition
Metabolites
Measurement errors
Oxidants
Metabolism
Type 2 Diabetes Mellitus

Keywords

  • 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid
  • Furan fatty acids
  • Metabolism
  • Renal failure
  • Type 2 diabetes

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology

Cite this

Furan fatty acids – Beneficial or harmful to health? / Xu, Long; Sinclair, Andrew J.; Faiza, Muniba; Li, Daoming; Han, Xianlin; Yin, Huiyong; Wang, Yonghua.

In: Progress in Lipid Research, Vol. 68, 01.10.2017, p. 119-137.

Research output: Contribution to journalReview article

Xu, L, Sinclair, AJ, Faiza, M, Li, D, Han, X, Yin, H & Wang, Y 2017, 'Furan fatty acids – Beneficial or harmful to health?', Progress in Lipid Research, vol. 68, pp. 119-137. https://doi.org/10.1016/j.plipres.2017.10.002
Xu, Long ; Sinclair, Andrew J. ; Faiza, Muniba ; Li, Daoming ; Han, Xianlin ; Yin, Huiyong ; Wang, Yonghua. / Furan fatty acids – Beneficial or harmful to health?. In: Progress in Lipid Research. 2017 ; Vol. 68. pp. 119-137.
@article{615f92417cc54abe87090933f684df65,
title = "Furan fatty acids – Beneficial or harmful to health?",
abstract = "Furan fatty acids are found in plants, algae, and fish, and reported to have some positive health benefits, including anti-oxidant and anti-inflammatory activities, and inhibition of non-enzymatic lipid peroxidation. A major metabolite of furan fatty acids, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF), has been reported to be increased in patients who progress from prediabetes to type 2 diabetes, although CMPF is not necessarily associated with impaired glucose metabolism. Other studies report that CMPF levels are lower in subjects with diabetes than control subjects. Plasma CMPF levels increase in subjects who consume fish or fish oil, and in patients with renal failure. It is not known where furan fatty acids are converted to CMPF and it is speculated that this might be a result of microbiome activity. The plasma levels reported for CMPF in healthy, diabetic and patients with renal disease vary by factors of more than 100-fold within each of these three groups, so measurement error appears to be limiting the ability to interpret studies. This review explores these controversies and raises questions about whether CMPF is a marker for healthy diets or indeed associated with diabetes and renal health. The review concludes that, on balance, furan fatty acids are beneficial for health.",
keywords = "3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, Furan fatty acids, Metabolism, Renal failure, Type 2 diabetes",
author = "Long Xu and Sinclair, {Andrew J.} and Muniba Faiza and Daoming Li and Xianlin Han and Huiyong Yin and Yonghua Wang",
year = "2017",
month = "10",
day = "1",
doi = "10.1016/j.plipres.2017.10.002",
language = "English (US)",
volume = "68",
pages = "119--137",
journal = "Progress in Lipid Research",
issn = "0163-7827",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Furan fatty acids – Beneficial or harmful to health?

AU - Xu, Long

AU - Sinclair, Andrew J.

AU - Faiza, Muniba

AU - Li, Daoming

AU - Han, Xianlin

AU - Yin, Huiyong

AU - Wang, Yonghua

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Furan fatty acids are found in plants, algae, and fish, and reported to have some positive health benefits, including anti-oxidant and anti-inflammatory activities, and inhibition of non-enzymatic lipid peroxidation. A major metabolite of furan fatty acids, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF), has been reported to be increased in patients who progress from prediabetes to type 2 diabetes, although CMPF is not necessarily associated with impaired glucose metabolism. Other studies report that CMPF levels are lower in subjects with diabetes than control subjects. Plasma CMPF levels increase in subjects who consume fish or fish oil, and in patients with renal failure. It is not known where furan fatty acids are converted to CMPF and it is speculated that this might be a result of microbiome activity. The plasma levels reported for CMPF in healthy, diabetic and patients with renal disease vary by factors of more than 100-fold within each of these three groups, so measurement error appears to be limiting the ability to interpret studies. This review explores these controversies and raises questions about whether CMPF is a marker for healthy diets or indeed associated with diabetes and renal health. The review concludes that, on balance, furan fatty acids are beneficial for health.

AB - Furan fatty acids are found in plants, algae, and fish, and reported to have some positive health benefits, including anti-oxidant and anti-inflammatory activities, and inhibition of non-enzymatic lipid peroxidation. A major metabolite of furan fatty acids, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF), has been reported to be increased in patients who progress from prediabetes to type 2 diabetes, although CMPF is not necessarily associated with impaired glucose metabolism. Other studies report that CMPF levels are lower in subjects with diabetes than control subjects. Plasma CMPF levels increase in subjects who consume fish or fish oil, and in patients with renal failure. It is not known where furan fatty acids are converted to CMPF and it is speculated that this might be a result of microbiome activity. The plasma levels reported for CMPF in healthy, diabetic and patients with renal disease vary by factors of more than 100-fold within each of these three groups, so measurement error appears to be limiting the ability to interpret studies. This review explores these controversies and raises questions about whether CMPF is a marker for healthy diets or indeed associated with diabetes and renal health. The review concludes that, on balance, furan fatty acids are beneficial for health.

KW - 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid

KW - Furan fatty acids

KW - Metabolism

KW - Renal failure

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85032191295&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032191295&partnerID=8YFLogxK

U2 - 10.1016/j.plipres.2017.10.002

DO - 10.1016/j.plipres.2017.10.002

M3 - Review article

C2 - 29051014

AN - SCOPUS:85032191295

VL - 68

SP - 119

EP - 137

JO - Progress in Lipid Research

JF - Progress in Lipid Research

SN - 0163-7827

ER -